Biopool International gains approval for five more reagents:
This article was originally published in Clinica
Executive Summary
Five chemistry reagent systems developed by Biopool International have been approved for marketing in the US. The five reagents - blood urea nitrogen, creatine kinase, alanine aminotransferase, lactate dehydrogenase and triglycerides - together with the lipase reagent approved last year form the beginning of a panel of 15 tests Biopool plans to develop over the next year. The clinical chemistry reagents will compete in a market estimated at $2,000 million.